
Bayer · Bayer Space
Development of a scientific hub dedicated to transthyretin cardiac amyloidosis.
- Client
- Bayer
- Suite
- deltaPharma
- Type
- Scientific hub · UX/UI & development
Context
Transthyretin cardiac amyloidosis (ATTR-CM) is a rare, complex and often underdiagnosed disease. For a global leader like Bayer, the challenge was to create a digital space of the highest scientific profile, able to drive disease awareness and medical education for clinicians and specialists.
Solution
Working in close synergy with ADVS, which led the initiative as project lead, we handled the information architecture, the user-interface design (UI/UX) and the technical development of the vertical section within the “Bayer Space” hub. The platform was optimised to host clinical insights, diagnostic pathways and cutting-edge medical-scientific content.
Impact
The project is the flagship of our Pharma division. Together with ADVS, we delivered Bayer a solid, secure digital touchpoint, perfectly compliant with the sector's strict regulatory standards, which became a reference point for cardiologists and healthcare professionals committed to the early diagnosis of this disease.
Got something like this in mind?
Ask your consultant